图源:网络1月13日,JPMorgan大会召开之际,强生宣布了一个大消息:将以146亿美元收购一家开发中枢神经治疗药物的企业Intra-cellular。这一金额超过了强生自己创下的2024年全球医药企业收购金额记录。去年4月,强生花费131亿美元收购Shockwave医疗,不到一年再度出手,剑指一款抗抑郁“神药”卢美哌隆。Intra-cellular是诺贝尔奖得主Paul Greengard在...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.